COCBC17/2
TARGET AUDIENCE
This activity is intended for medical oncologists, oncology fellows, oncology nurses and other healthcare providers involved in the treatment of breast cancer. OVERVIEW OF ACTIVITY LEARNING OBJECTIVES
ACCREDITATION STATEMENT CME credit is no longer available for this issue CREDIT DESIGNATION STATEMENT CME credit is no longer available for this issue AMERICAN BOARD OF INTERNAL MEDICINE (ABIM) — MAINTENANCE OF CERTIFICATION (MOC) CME credit is no longer available for this issue HOW TO USE THIS CME ACTIVITY CME credit is no longer available for this issue CONTENT VALIDATION AND DISCLOSURES FACULTY — The following faculty (and their spouses/partners) reported relevant conflicts of interest, which have been resolved through a conflict of interest resolution process: Sarat Chandarlapaty, MD, PhD Consulting Agreements: Agendia Inc, AstraZeneca Pharmaceuticals LP, Chugai Pharmaceutical Co Ltd, MacroGenics Inc, Sermonix Pharmaceuticals; Contracted Research: Lilly, Novartis Pharmaceuticals Corporation. William J Gradishar, MD No financial interests or affiliations to disclose. Kathy D Miller, MD Contracted Research: Astellas Pharma Global Development Inc, Genentech BioOncology, Medivation Inc, Merrimack Pharmaceuticals Inc, Novartis Pharmaceuticals Corporation, Pfizer Inc, Taiho Oncology Inc; Data Monitoring Committee: ImClone Systems, a wholly owned subsidiary of Eli Lilly and Company, Merck. Ruth M O’Regan, MD Advisory Committee: bioTheranostics Inc, Lilly, Pfizer Inc; Contracted Research: Novartis Pharmaceuticals Corporation, Pfizer Inc. Lee S Schwartzberg, MD Consulting Agreements: Amgen Inc, Bristol-Myers Squibb Company, Genomic Health Inc, Pfizer Inc, Spectrum Pharmaceuticals Inc; Speakers Bureau: Genentech BioOncology. Melinda L Telli, MD Advisory Committee: Tesaro Inc, Vertex Pharmaceuticals Incorporated; Consulting Agreement: AstraZeneca Pharmaceuticals LP; Contracted Research: Abbott Laboratories, Calithera Biosciences, Genentech BioOncology, Medivation Inc, OncoSec Medical, PharmaMar, Vertex Pharmaceuticals Incorporated. Sarah M Tolaney, MD, MPH Contracted Research: Genentech BioOncology, Lilly, Merck, Novartis Pharmaceuticals Corporation, Pfizer Inc. Denise A Yardley, MD Advisory Committee: Novartis Pharmaceuticals Corporation; Speakers Bureau: Eisai Inc, Genentech BioOncology. EDITOR — Dr Love is president and CEO of Research To Practice, which receives funds in the form of educational grants to develop CME activities from the following commercial interests: AbbVie Inc, Acerta Pharma, Agendia Inc, Amgen Inc, Ariad Pharmaceuticals Inc, Array BioPharma Inc, Astellas Pharma Global Development Inc, AstraZeneca Pharmaceuticals LP, Baxalta Inc, Bayer HealthCare Pharmaceuticals, Biodesix Inc, bioTheranostics Inc, Boehringer Ingelheim Pharmaceuticals Inc, Boston Biomedical Pharma Inc, Bristol-Myers Squibb Company, Celgene Corporation, Clovis Oncology, CTI BioPharma Corp, Daiichi Sankyo Inc, Dendreon Pharmaceuticals Inc, Eisai Inc, Exelixis Inc, Foundation Medicine, Genentech BioOncology, Genomic Health Inc, Gilead Sciences Inc, Halozyme Therapeutics, ImmunoGen Inc, Incyte Corporation, Infinity Pharmaceuticals Inc, Janssen Biotech Inc, Jazz Pharmaceuticals Inc, Lilly, Medivation Inc, Merck, Merrimack Pharmaceuticals Inc, Myriad Genetic Laboratories Inc, NanoString Technologies, Natera Inc, Novartis Pharmaceuticals Corporation, Novocure, Onyx Pharmaceuticals, an Amgen subsidiary, Pharmacyclics LLC, an AbbVie Company, Prometheus Laboratories Inc, Regeneron Pharmaceuticals, Sanofi, Seattle Genetics, Sigma-Tau Pharmaceuticals Inc, Sirtex Medical Ltd, Spectrum Pharmaceuticals Inc, Taiho Oncology Inc, Takeda Oncology, Tesaro Inc, Teva Oncology, Tokai Pharmaceuticals Inc and VisionGate Inc. RESEARCH TO PRACTICE STAFF AND EXTERNAL REVIEWERS — The scientific staff and reviewers for Research To Practice have no relevant conflicts of interest to disclose. This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantors. This activity is supported by educational grants from Celgene Corporation, Genentech BioOncology, Genomic Health Inc, Lilly and Novartis Pharmaceuticals Corporation. Hardware/Software Requirements: Last review date: February 2017 |